Abstract:AIM: To study the apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.METHODS: Sixty gastric cancer patients were divided randomly into three groups (20 each group) before operation: group one: 5'-DFUR oral administration at the dose of 800-1200 mg/d for 3 - 5 cl, group two: 500mg 5-FU + 200 mg/d CF by venous drip for 3 - 5 cl, group three (control group). One or two days after chemotherapy, the patients were operated. Fas/FasL, PD-ECGF and PCNA were examined by immunohistochemistry and apoptotic tumor cells were detected by in situ TUNEL method. Fifty-four patients received gastrectomy, including 12 palliative resections and 42 radical resections. Six patients were excluded. Finally 18 cases in 5'-DFUR group, 16 cases in CF + 5-FU group, and 20 cases in control group were analyzed.RESULTS: There was no significant difference in patient mean age, gender, white blood cell count, haematoglobin (HB), thromboplastin, perioperative complication incidence, radical or palliation resection, invasion depth (T), lymphonode involvement (N), metastasis (M) and TNM staging among the three groups. However, the PCNA index (PI) in 5'-DFUR group (40.51 +/- 12.62) and 5-FU + CF group (41.12 +/- 15.26) was significantly lower than that in control group (58.33 +/- 15.69) (F = 9.083, P = 0.000). The apoptotic index (AI) in 5'-DFUR group (14.39 +/- 9.49) and 5-FU + CF group (14.11 +/- 9.68) was significantly higher than that in control group (6.88 +/- 7.37) (F = 4.409, P = 0.017). The expression rates of Fas and FasL in group one and group three were 66.7% (12/18) and 50% (9/18), 43.8% (7/16) and 81.3% (13/16), 45.0% (9/20) and 85% (17/20), respectively. The expression rate of FasL in 5'-DFUR group was significantly lower than that in the other two groups (chi(2) = 6.708, P = 0.035). Meanwhile, the expression rate of PD-ECGF was significantly lower in 5'-DFUR group (4/18, 28.6%) than in CF + 5-FU group (9/16, 56.3%) and control group (13/20, 65.0%) (chi(2) = 7.542, P = 0.023). The frequency of Fas expression was significantly correlated with palliative or radical resection (chi(2) = 7.651, P = 0.006), invasion depth (chi(2) = 8.927, P = 0.003), lymphatic spread (chi(2) = 4.488, P = 0.034) and UICC stages (chi(2) = 8.063, P = 0.045) respectively. By the end of March 2005, 45 patients were followed up. The 0.5-, 1-, 2-, 3-year survival rates were 96%, 73%, 60%, 48%, respectively, which were related with T, N, M and Fas expression, but not with PD-ECGF and FasL expression.CONCLUSION: Preoperative oral 5'-DFUR administration may induce apoptosis of gastric carcinoma cells and decrease tumor cell proliferation index, but cannot improve the prognosis of patients with gastric cancer. Downregulation of FasL and PD-ECGF expression mediated by 5'-DFUR may be one of its anti-cancer mechanisms. Fas expression correlates with the progression of gastric carcinoma and may be an effective prognostic factor. (C) 2006 The WJG Press. All rights reserved.

[The Effect of Pre-Operative Chemotherapy on Calpain in Cells of Gastrointestinal Malignant Tumors].

Pre-operative radiochemotherapy of locally advanced rectal cancer.

Short Term Therapeutic Effect on Treatment of Postoperational Large Intestine Carcinoma by Fupiyiwei Decoction Combined with Chemotherapy and It's Effect on Immune Fuction

[Effect of Preoperative Oral 5'-DFUR on PyNPase Level in Gastrointestinal Malignant Tumor Tissues].

A Clinical Study on Apoptosis and Proliferation of Gastric Adenocarcinoma Cells Induced by 5'-Deoxy-5-fluorouridine (5'-DFUR)

Apoptosis Induced by Preoperative Oral 5’-DFUR Administration in Gastric Adenocarcinoma and Its Mechanism of Action

Effects of Preoperative Arterial Infusion Chemotherapy with Oxaliplatin and 5-FU for Patients with Advanced Gastric Cancer

Effect of preoperative oral S-1 combined with regional intra-arterial chemotherapy on malig-nant molecule expression in locally advanced unresectabIe gastric cancer tissue

Effect of Preoperative Hepatic and Regional Arterial Chemotherapy on Metachronous Liver Metastasis after Curative Colorectal Cancer Resection: A Prospective, Multicenter, Randomized Controlled Trial

[Effect of the Change of Caspase-3 Activity on the Neoadjuvant Chemotherapy-Induced Apoptosis of Large-Intestinal Carcinoma Cells].

The Effect of Adriamycin Magnetic Fluid Targeting Chemotherapy Before Operation on Apoptosis and Proliferaton of Advanced Gastric Cancer Cells

Comparing the Effect of Adjuvant Chemotherapy by Portal Vein Infusion with Intraluminal Chemotherapy for Colorectal Cancer

[Effect of Preoperative Radiotherapy As an Adjunctive Approach on Proliferation and Apoptosis of Cancer Cells in Rectal Cancer].

Protective Effect of Curcumin on Chemotherapy-Induced Intestinal Dysfunction.

The observation of short-term effect of induction chemotherapy of docetaxel combined with cisplatin and fluorouracil for oral mucosal squamous cell carcinoma

A dose-effect analysis of organs at risk during preoperative chemoradiotherapy for gastric cancer

THE EFFECT OF TOTAL PARENTERAL NUTRITION SUPPLEMENTED WITH SHORT-CHAIN FATTYACIDS OF THE PROLIFERATION OF COLON MUCOSAL CELLS IN RATS WITH POSTOPERATIVE CHEMOTHERAPY

Impacts of Preoperative Radiochemotherapy on Operation and Postoperative Complications in Patients with Mid-Low Rectal Carcinomas

[Preoperative Arterial Infusion Chemotherapy of Colorectal Carcinoma Pathological and Clinical Effects].

Efficacy and Safety of Preoperative Immunotherapy in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Gastrointestinal Malignancies

Safety and effects of different type of intra-peritoneal implantation of sustained-releasing 5-fluorouracil in patients with gastrointestinal cancer